# Minimum Compliance Profile (MCP)
## Constitutional Execution Requirements for Pharmaceutical Reproducibility

The Minimum Compliance Profile (MCP) defines the mandatory conditions that a
pharmaceutical synthesis sequence MUST satisfy to be recognized as
constitutionally valid under the Pharma Domain.

Normative reference:  
Russell, “Constitutional Mathematics for Pharmaceutical Reproducibility”
(SSRN‑6816078, May 22, 2026)

A process is MCP‑Compliant if and only if ALL conditions below are satisfied.
Failure of ANY condition MUST result in BLOCK.

---

## 1. Continuous Ledger Logging

For all refinement steps \(k \ge k_{\min}\):

- a valid ledger entry \(T_k\) MUST exist  
- each entry MUST be hash‑linked to the previous entry  
- each entry MUST include:  
  - \(H(P_{\text{raw}})\)  
  - iteration index \(k\)  
  - HPLC‑MS metadata hash \(M_{\text{HPLC}}\)  
  - validation state \(S_{\text{state}}\)  
  - constitutional classification \(M(Y_k)\)

Ledger anchoring is mandatory under Axiom V.

---

## 2. Impurity Threshold (Purity Gate)

HPLC‑MS analytics MUST confirm:

\[
imp(Y) < 0.1\%
\]

This threshold is derived from ICH Q3A(R2) identification limits.

Any state with impurity ≥ 0.1% MUST be rejected.

---

## 3. Full F27 Component Verification

All 27 components \(C_1 \dots C_{27}\) MUST be:

- instantiated  
- validated  
- anchored to the ledger  

Verification rule:

\[
V_i(Y) \ge \theta_i \quad \text{AND} \quad audit_i \in \mathcal{L}
\]

Nominal threshold:

\[
\theta_i = 0.95
\]

Failure of ANY component MUST result in BLOCK.

---

## 4. Gas Convergence Constraint

For every refinement pass \(k\):

\[
Gas_k \in 98.2\% \pm 0.7\%
\]

This enforces Axiom VII.

If gas usage falls outside this interval, the refinement pass MUST be rejected.

---

## 5. Constitutional Axiom Satisfaction

All Seven Constitutional Axioms MUST evaluate TRUE:

\[
\forall i \in \{1,\dots,7\}: A_i(Y_c, Y_p) = 1
\]

If ANY axiom evaluates FALSE:

- the system MUST emit BLOCK  
- the violated axiom index MUST be recorded  
- refinement MUST halt  

---

## 6. R³ Convergence to a Unique Fixed Point

The R³ recursion MUST converge to a unique fixed point \(Y^*\):

\[
\|Y_k - Y_{k-1}\|_v < \varepsilon
\]

with:

\[
\varepsilon = 10^{-15}
\]

If R³ fails to converge, the process MUST be rejected.

---

## 7. Pre‑Clinical Ledger Anchoring

Before any clinical testing begins:

- all precursor hashes  
- all metadata hashes  
- all refinement hashes  
- all F27 component verifications  

MUST be anchored to an IEEE‑2418 compliant ledger.

No exceptions.

---

## 8. MCP Summary (All Conditions MUST Be True)

A process is MCP‑Compliant if and only if:

1. Continuous ledger logs exist for all \(k \ge k_{\min}\).  
2. Impurity < 0.1%.  
3. All 27 components verified and anchored.  
4. Gas convergence ∈ 98.2% ± 0.7%.  
5. All Seven Axioms evaluate TRUE.  
6. R³ converges to a unique fixed point \(Y^*\).  
7. All hashes anchored before clinical testing.

Failure of ANY condition ⇒ **BLOCK**.

---

## 9. Integration with PCIS‑1

PCIS‑1 uses the MCP as:

- the constitutional acceptance criteria  
- the BLOCK/PASS enforcement layer  
- the final gate before fixed‑point certification  
- the compliance profile for pharmaceutical reproducibility  

The MCP is mandatory for all Pharma Domain systems.
